Owc Pharmaceutical Research (OWCP) Return on Assets ROA from the third quarter of 2019 to third quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Owc Pharmaceutical Research Corp.  (OWCP)


Owc Pharmaceutical Research's ROA from the third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Owc Pharmaceutical Research's ROA in the third quarter of 2019?
Owc Pharmaceutical Research Corp. achieved a return on average assets (ROA) of 50.85 % in its third quarter of 2019, which is below Owc Pharmaceutical Research's average return on assets, which stands at 914.89%.

Despite the company's net income deteriorating, Owc Pharmaceutical Research was able to improve its ROA compared to the second quarter of 2019.

However, within the Healthcare sector 19 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2019 quarter, so far to 89, from total ROA ranking in the second quarter of 2019 at 250.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Total Assets Change -59.97 % -52.2 % 300.59 % 234.83 % 253.89 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 1 1 -10 -10 -7
Return On Assets (TTM) 50.85 % 19.31 % -263.84 % -306.78 % -244.6 %
OWCP's Total Ranking # 89 # 250 # 4949 # 5491 # 4886
Total Assets (TTM) in million 2 2 3 4 4
Seq. Total Assets Change -24.36 % -22.62 % -17 % -17.6 % -9.68 %
Seq. Net Income Change - - - - -

OWCP's 5 Years Annual ROA >> Back to OWCP Management Effectiveness >> Compare OWCP ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 4
Sector # 20
Overall # 81

Return On Assets Statistics
High Average Low
17720.79 %
914.89 %
-756.98 %
(Dec 31 2013)   (Dec 31 2016)





Financial Statements
Owc Pharmaceutical Research's Assets $ 2 million OWCP's Balance sheet
Owc Pharmaceutical Research's Income $ 0 million Quarterly OWCP's Income Statement
OWCP's Income by Division See OWCP's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015		 (Dec 31 2014)
FY 2014
Y / Y Total Assets Change 234.83 % 113.61 % 15.39 % -71.73 % 61577.28 %
Total Assets in million 4 1 0 0 2
Y / Y Net Income Change - - - - -
Net Income in million -10 -5 -2 -2 -5
Annual Return On Assets -288.71 % -429.59 % -460.44 % -384.44 % -332.98 %

OWCP's 5 Years Annual ROA >> Back to OWCP Management Effectiveness >> Compare OWCP ROA to its Competitors



More Return On Assets Ratios
OWCP's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OWCP's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OWCP's Competitors
Subscribers only: Roa for Owc Pharmaceutical Research's Suppliers
Subscribers only: Return On Assets for OWCP's Customers

You may also want to know
OWCP's Roi OWCP's Inventory Turnover Ratio OWCP's Growth Rates OWCP's Dividend Comparisons
OWCP's Profitability Ratios OWCP's Asset Turnover Ratio OWCP's Dividend Growth
OWCP's Roe OWCP's Valuation Ratios OWCP's Financial Strength Ratios OWCP's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2019, within Healthcare Sector ROA
Semler Scientific inc   120.02 %
Jounce Therapeutics inc   111.97 %
Aveo Pharmaceuticals Inc   91.53 %
Innoviva Inc   65.51 %
Palatin Technologies Inc   59.27 %
Oxford Immunotec Global Plc  59.04 %
Lexicon Pharmaceuticals Inc   53.91 %
Iveric Bio Inc   52.97 %
Kaya Holdings Inc   52.47 %
Owc Pharmaceutical Research Corp.  50.37 %
Arena Pharmaceuticals Inc   48.82 %
Molecular Templates Inc   47.66 %
Viskase Holdings inc   46.98 %
Zynex inc   43.30 %
Exelixis Inc   38.32 %
Ligand Pharmaceuticals Incorporated  36.43 %
Oramed Pharmaceuticals Inc  35.60 %
Vanda Pharmaceuticals Inc   31.81 %
Orgenesis Inc   31.38 %
Vertex Pharmaceuticals Inc  31.00 %
Strongbridge Biopharma plc  29.96 %
Nrc Health  29.69 %
Biocorrx Inc   28.44 %
Remedent Inc   28.29 %
Corcept Therapeutics Inc  26.15 %
Harrow Inc   26.14 %
Idexx Laboratories Inc  25.50 %
Siga Technologies Inc  24.34 %
Arrowhead Pharmaceuticals Inc   24.01 %
Biospecifics Technologies Corp  21.86 %

Date modified: 2026-06-22T16:30:23+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.